Related Experiment Video

Updated: Aug 10, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Rheumatoid arthritis: developing pharmacological therapies

Joel D Abbott1, Larry W Moreland

  • 1University of Alabama at Birmingham, Department of Medicine; Division of Clinical Immunology and Rheumatology, 1717 6th Avenue South, SRC 068, Birmingham, AL 35294-7201, USA.

Expert Opinion on Investigational Drugs
|July 23, 2004
PubMed

Insights

Rheumatoid arthritis (RA) treatments are evolving with new biological agents targeting specific pathways. Newer therapies focus on inhibiting T- and B-cell activity and cognate signaling for improved patient outcomes.

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory condition causing significant disability and mortality.
  • Advances in understanding RA pathogenesis have driven the development of novel therapeutic strategies.
  • The introduction of biological agents has revolutionized RA treatment paradigms over the past two decades.

Purpose of the Study:

  • To review the evolving landscape of pharmacological therapies for rheumatoid arthritis.
  • To emphasize novel treatment approaches targeting specific molecular pathways and immune cells in RA.
  • To discuss the impact of recent biological therapies on RA management.

Main Methods:

  • Review of current literature on rheumatoid arthritis treatment.
  • Analysis of the development and application of biological agents.
  • Focus on emerging therapeutic targets including cognate signaling, T-cells, and B-cells.

Main Results:

  • Biological therapies, including TNF-alpha and IL-1 antagonists, have demonstrated success in RA treatment.
  • Newer agents like rituximab and abatacept are being evaluated for their efficacy in rheumatic diseases.
  • Interest is growing in targeting specific immune cell functions and signaling pathways.

Conclusions:

  • The treatment of rheumatoid arthritis is rapidly advancing with the advent of targeted biological therapies.
  • Inhibition of cognate signaling and specific T- and B-cell targets represent promising future directions for RA pharmacotherapy.
  • Continued research into novel therapeutic targets is crucial for improving outcomes for patients with RA.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...